VeriMomr-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) hamilelikte güvenli mi?
No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR findings indicating reproductive hazard for these cosmetic peptides. No peer‑reviewed evidence of teratogenicity or reproductive toxicity for these named oligopeptide/hexapeptide cosmetic ingredients was identified in available cosmetic safety sources, and peptides of this size are generally considered of low dermal absorption in topical use (CIR/CosIng/PubChem review).
Related ingredients
Frequently asked questions
- r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) hamilelikte güvenli mi?
- No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR findings indicating reproductive hazard for these cosmetic peptides. No peer‑reviewed evidence of teratogenicity or reproductive toxicity for these named oligopeptide/hexapeptide cosmetic ingredients was identified in available cosmetic safety sources, and peptides of this size are generally considered of low dermal absorption in topical use (CIR/CosIng/PubChem review).
- r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) emzirirken güvenli mi?
- Same rationale as pregnancy: no harmonised classifications or authoritative cosmetic safety assessments indicating reproductive/lactation risk. Large peptide molecules used topically have low systemic availability; no data indicate transfer into breast milk or effects on nursing infants.
- r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) bebek cildi için güvenli mi?
- No evidence of intrinsic reproductive or developmental hazard. Mechanistic data lacking. Exposure score increased by +1 for infants (e=1) because, although adult dermal absorption is expected to be negligible for large peptides, infant skin has higher absorption potential and immature barrier function, so measurable exposure cannot be excluded.
- VeriMom r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) nasıl puanlıyor?
- VeriMom r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48)'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte r-(aspartyl oligopeptide-162 hexapeptide-40 aspartyl rh-polypeptide-114)/r- (aspartyl oligopeptide-162 aspartyl rh-polypeptide-115)/r-( aspartyl oligopeptide-162 aspartyl rh-polypeptide-48) yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.